2.545

2.87% -0.065

Maravai Lifesciences Holdings Inc (MRVI)

Overview News Price History Option Chain Financials Why MRVI Down? Discussions Forecast

Maravai Lifesciences Holdings Inc stock is traded at $2.545, with a volume of 437.95K. It is down -2.87% in the last 24 hours and down -38.47% over the past month. Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Previous Close:

$2.61

Open:

$2.58

24h Volume:

437.95K

Relative Volume:

0.17

Market Cap:

$361.70M

Revenue:

$288.95M

Net Income/Loss:

$-119.03M

P/E Ratio:

-2.8262

EPS:

-0.9005

Net Cash Flow:

$60.67M

1W Performance:

-5.06%

1M Performance:

-38.47%

6M Performance:

-69.79%

1Y Performance:

-67.91%

1-Day Range:

$2.52

$2.62

1-Week Range:

$2.52

$3.055

52-Week Range:

$2.52

$11.55

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name

Maravai Lifesciences Holdings Inc

Sector

Healthcare (1172)

Industry

Biotechnology (680)

Phone

(858) 546-0004

Address

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Employee

580

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

MRVI's Discussions on Twitter

Compare MRVI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MRVI Maravai Lifesciences Holdings Inc	2.545	361.70M	288.95M	-119.03M	60.67M	-0.9005
VRTX Vertex Pharmaceuticals Inc	501.64	130.96B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	685.01	75.53B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	579.08	35.07B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	242.49	31.72B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	250.25	26.76B	3.32B	-860.46M	-1.04B	-8.32

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-25	Downgrade	Robert W. Baird	Outperform → Neutral
Dec-19-24	Initiated	Guggenheim	Neutral
Dec-05-24	Downgrade	Goldman	Neutral → Sell
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Nov-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-24	Initiated	Wells Fargo	Overweight
Aug-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-10-24	Initiated	Craig Hallum	Buy
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Aug-05-21	Resumed	Credit Suisse	Outperform
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-15-20	Initiated	BofA Securities	Buy
Dec-15-20	Initiated	Credit Suisse	Outperform
Dec-15-20	Initiated	Goldman	Buy
Dec-15-20	Initiated	Jefferies	Buy
Dec-15-20	Initiated	Robert W. Baird	Outperform
Dec-15-20	Initiated	Stifel	Buy
Dec-15-20	Initiated	William Blair	Outperform
Dec-14-20	Initiated	UBS	Buy

View All

Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News

05:45 AM

The Gross Law Firm Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMRVI - PR Newswire

05:45 AM

Mar 12, 2025

Marvai LifeSciences Holdings, Inc. Shareholders with Large Losses are Encouraged to Contact Robbins LLP for Information About Leading the Securities Fraud Class Action Lawsuit Against MRVI - GlobeNewswire

Mar 12, 2025

Marvai LifeSciences Holdings, Inc. Shareholders with Large - GlobeNewswire

Mar 12, 2025

Marvai LifeSciences Holdings, Inc. Shareholders with Large Losses are Encouraged to Contact Robbins LLP for Information About Leading the Securities Fraud Class Action Lawsuit Against MRVI - GlobeNewswire Inc.

Mar 12, 2025

MRVI INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire

Mar 12, 2025

Lowey Dannenberg Notifies Maravai LifeSciences Holdings, - GlobeNewswire

Mar 12, 2025

Levi & Korsinsky Notifies Shareholders of Maravai LifeSciences Holdings, Inc. (MRVI) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Mar 12, 2025

Deadline Alert: Maravai LifeSciences Holdings, Inc. (MRVI) - GlobeNewswire

Mar 12, 2025

Shareholders that lost money on Maravai LifeSciences Holdings, Inc.(MRVI) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire

Mar 12, 2025

Levi & Korsinsky Reminds Maravai LifeSciences Holdings, Inc. Inv - GuruFocus.com

Mar 12, 2025

Levi & Korsinsky Reminds Maravai LifeSciences Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025MRVI - PR Newswire

Mar 12, 2025

Mar 11, 2025

Class Action Announcement for Maravai LifeSciences - GlobeNewswire

Mar 11, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming DeadlinesMRVI - PR Newswire

Mar 11, 2025

NASDAQ: MRVI Lawsuit Alert: Investors with substantial losses from shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) purchased between Aug. 2024 and Feb. 2025 should contact the Shareholders Foundation - PR Newswire

Mar 11, 2025

Maravai Lifesciences stock hits 52-week low at $2.63 - Investing.com India

Mar 11, 2025

Maravai Lifesciences stock hits 52-week low at $2.63 By Investing.com - Investing.com South Africa

Mar 11, 2025

Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI)May 5, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Mar 11, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - GlobeNewswire

Mar 11, 2025

Mar 10, 2025

Maravai LifeSciences Holdings, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 5, 2025 to Discuss Your RightsMRVI - ACCESS Newswire

Mar 10, 2025

MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces - WICZ

Mar 10, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Maravai - GlobeNewswire

Mar 10, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to ... - Bluefield Daily Telegraph

Mar 10, 2025

MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire

Mar 10, 2025

Class Action Filed Against Maravai LifeSciences Holdings, - GlobeNewswire

Mar 10, 2025

Law Offices of Frank R. Cruz Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors To Inquire About Securities Fraud Class Action - Business Wire

Mar 10, 2025

MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Mar 10, 2025

MRVI INVESTOR DEADLINE: Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire

Mar 10, 2025

MRVI LAWSUIT ALERT: The Gross Law Firm Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire

Mar 10, 2025

Mar 09, 2025

MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 09, 2025

Mar 08, 2025